Dexcel Pharma Technologies Ltd. insider trades: Roivant Sciences (ROIV) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dexcel Pharma Technologies Ltd. reports to the SEC
and 1 more company
Open-market buys and sales
29 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 10, 2022 | ROIV | ↑ Buy | 4,000,000 | $5.00 | $20.0M | Direct | Nov 14, 2022 (4d) |
| Apr 25, 2022 | ROIV | ↑ Buy | 40,285 | $3.85 | $155K | Direct | Apr 26, 2022 (1d) |
| Jun 3, 2021 | PLX | ↓ Sell | 918,717 | $2.27 | $2.1M | Direct | Jun 3, 2021 (0d) |
| Feb 4, 2020 | NTEC | ↓ Sell | 915,951 | $0.31 | $282K | Direct | Feb 4, 2020 (0d) |
| Jun 19, 2019 | UROV | ↑ Buy10b5-1 | 11,663 | $8.19 | $96K | Indirect | Jun 19, 2019 (0d) |
| Jun 17, 2019 | UROV | ↑ Buy10b5-1 | 6,541 | $8.53 | $56K | Indirect | Jun 19, 2019 (2d) |
| Jun 14, 2019 | UROV | ↑ Buy10b5-1 | 14,511 | $7.93 | $115K | Indirect | Jun 14, 2019 (0d) |
| Jun 12, 2019 | UROV | ↑ Buy10b5-1 | 7,500 | $8.30 | $62K | Indirect | Jun 14, 2019 (2d) |
| Jun 11, 2019 | UROV | ↑ Buy10b5-1 | 14,689 | $8.46 | $124K | Indirect | Jun 11, 2019 (0d) |
| Jun 7, 2019 | UROV | ↑ Buy10b5-1 | 6,649 | $7.96 | $53K | Indirect | Jun 11, 2019 (4d) |
| Jun 6, 2019 | UROV | ↑ Buy10b5-1 | 13,622 | $8.00 | $109K | Indirect | Jun 6, 2019 (0d) |
| Jun 4, 2019 | MYOV | ↑ Buy | 2,424,242 | $8.25 | $20.0M | Indirect | Jun 6, 2019 (2d) |
| Jun 4, 2019 | UROV | ↑ Buy10b5-1 | 7,500 | $7.59 | $57K | Indirect | Jun 6, 2019 (2d) |
| Jun 3, 2019 | UROV | ↑ Buy10b5-1 | 10,795 | $7.74 | $84K | Indirect | Jun 3, 2019 (0d) |
| May 30, 2019 | UROV | ↑ Buy10b5-1 | 6,951 | $7.97 | $55K | Indirect | Jun 3, 2019 (4d) |
| May 29, 2019 | UROV | ↑ Buy10b5-1 | 10,689 | $7.60 | $81K | Indirect | May 29, 2019 (0d) |
| May 24, 2019 | UROV | ↑ Buy10b5-1 | 3,796 | $7.70 | $29K | Indirect | May 29, 2019 (5d) |
| May 23, 2019 | UROV | ↑ Buy10b5-1 | 4,802 | $7.76 | $37K | Indirect | May 28, 2019 (5d) |
| May 22, 2019 | UROV | ↑ Buy | 5,033 | $8.06 | $41K | Indirect | May 28, 2019 (6d) |
| May 21, 2019 | UROV | ↑ Buy | 9,995 | $8.52 | $85K | Indirect | May 23, 2019 (2d) |
| May 20, 2019 | UROV | ↑ Buy | 8,285 | $7.98 | $66K | Indirect | May 22, 2019 (2d) |
| May 20, 2019 | UROV | ↑ Buy | 1,715 | $8.39 | $14K | Indirect | May 22, 2019 (2d) |
| May 17, 2019 | UROV | ↑ Buy | 6,200 | $7.36 | $46K | Indirect | May 20, 2019 (3d) |
| May 16, 2019 | UROV | ↑ Buy | 5,408 | $6.79 | $37K | Indirect | May 20, 2019 (4d) |
| Mar 18, 2019 | AXON | ↑ Buy | 6,666,667 | $1.50 | $10.0M | Indirect | Mar 19, 2019 (1d) |
| Dec 18, 2018 | AXON | ↑ Buy | 10,000,000 | $1.00 | $10.0M | Indirect | Dec 20, 2018 (2d) |
| Oct 1, 2018 | UROV | ↑ Buy | 2,678,571 | $14.00 | $37.5M | Indirect | Oct 3, 2018 (2d) |
| Jun 5, 2018 | AXON | ↑ Buy | 14,285,714 | $1.75 | $25.0M | Indirect | Jun 7, 2018 (2d) |
| Apr 2, 2018 | MYOV | ↑ Buy | 1,110,015 | $20.27 | $22.5M | Indirect | Apr 4, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ROIV insiders
Open-market trades in the last 12 months
About Dexcel Pharma Technologies Ltd.'s insider trades
Dexcel Pharma Technologies Ltd. is a 10% owner of Roivant Sciences (ROIV). Since Apr 2, 2018, it has reported 27 open-market purchases worth $146.4M and 2 sales worth $2.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ROIV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.